Literature DB >> 16368217

Brain MRI abnormalities in muscular dystrophy due to FKRP mutations.

Susana Quijano-Roy1, Itxaso Martí-Carrera, Samira Makri, Michèle Mayer, Svetlana Maugenre, Pascale Richard, Carole Berard, Louis Viollet, Bruno Leheup, Pascale Guicheney, Jean-Marc Pinard, Brigitte Estournet, Robert Y Carlier.   

Abstract

INTRODUCTION: FKRP mutations cause a muscular dystrophy which may present in the neonatal period (MDC1C) or later in life (LGMD2I). Intelligence and brain imaging have been previously reported as being normal in FKRP-associated muscular dystrophy, except in rare cases presenting with mental retardation associated with structural brain abnormalities. PATIENTS AND METHODS: We studied cerebral MRIs in twelve patients with FKRP-associated muscular dystrophy presenting in infancy or early childhood, at ages between 14 months and 43 years. Two patients had severe cognitive deficits, four had mild-moderate mental retardation and the rest were considered to have normal intelligence. All, but one were wheelchair-bound and 7 were mechanically ventilated.
RESULTS: Brain MRI was abnormal in 9 of 12 patients. Brain atrophy was seen in 8 patients. One child had isolated ventricular enlargement at 4 years. Cortical atrophy involved predominantly temporal and frontal lobes and was most important at later ages. In two cases with serial images this atrophy seemed progressive. Three patients, two with severe and one with moderate mental retardation, showed structural abnormalities of the posterior fossa with hypoplasia of the vermis and pons, and cerebellar hemispheric cysts. These abnormalities were stable with time. Two of these three patients also showed diffuse white matter abnormalities in early childhood, which regressed with time.
CONCLUSIONS: MRI abnormalities are common in patients with FKRP-associated muscular dystrophy presenting at birth or in early childhood. Progressive brain atrophy is the most frequent finding. Posterior fossa malformations and transient white matter changes may be seen in patients with associated mental retardation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368217     DOI: 10.1016/j.braindev.2005.08.003

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  9 in total

1.  FKRP mutations, including a founder mutation, cause phenotype variability in Chinese patients with dystroglycanopathies.

Authors:  Xiaona Fu; Haipo Yang; Cuijie Wei; Hui Jiao; Shuo Wang; Yanling Yang; Chunxi Han; Xiru Wu; Hui Xiong
Journal:  J Hum Genet       Date:  2016-07-21       Impact factor: 3.172

2.  Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I.

Authors:  A Palmieri; R Manara; L Bello; G Mento; L Lazzarini; C Borsato; L Bortolussi; C Angelini; E Pegoraro
Journal:  J Neurol       Date:  2011-02-04       Impact factor: 4.849

3.  Muscle protein alterations in LGMD2I patients with different mutations in the Fukutin-related protein gene.

Authors:  Lydia U Yamamoto; Fernando J Velloso; Bruno L Lima; Luciana L Q Fogaça; Flávia de Paula; Natássia M Vieira; Mayana Zatz; Mariz Vainzof
Journal:  J Histochem Cytochem       Date:  2008-07-21       Impact factor: 2.479

4.  Comparison of brain MRI findings with language and motor function in the dystroglycanopathies.

Authors:  Brianna N Brun; Shelley R H Mockler; Katie M Laubscher; Carrie M Stephan; Anne M Wallace; Julia A Collison; M Bridget Zimmerman; William B Dobyns; Katherine D Mathews
Journal:  Neurology       Date:  2017-01-13       Impact factor: 9.910

Review 5.  Congenital muscular dystrophies: a brief review.

Authors:  Enrico Bertini; Adele D'Amico; Francesca Gualandi; Stefania Petrini
Journal:  Semin Pediatr Neurol       Date:  2011-12       Impact factor: 1.636

6.  Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I.

Authors:  Xiomara Q Rosales; Sean J Moser; Tam Tran; Beth McCarthy; Nicholas Dunn; Philip Habib; Orlando P Simonetti; Jerry R Mendell; Subha V Raman
Journal:  J Cardiovasc Magn Reson       Date:  2011-08-04       Impact factor: 5.364

7.  Clinical, genetic, and pathologic characterization of FKRP Mexican founder mutation c.1387A>G.

Authors:  Angela J Lee; Karra A Jones; Russell J Butterfield; Mary O Cox; Chamindra G Konersman; Carla Grosmann; Jose E Abdenur; Monica Boyer; Brent Beson; Ching Wang; James J Dowling; Melissa A Gibbons; Alison Ballard; Joanne S Janas; Robert T Leshner; Sandra Donkervoort; Carsten G Bönnemann; Denise M Malicki; Robert B Weiss; Steven A Moore; Katherine D Mathews
Journal:  Neurol Genet       Date:  2019-03-01

Review 8.  Discovery of Novel Therapeutics for Muscular Dystrophies using Zebrafish Phenotypic Screens.

Authors:  Jeffrey J Widrick; Genri Kawahara; Matthew S Alexander; Alan H Beggs; Louis M Kunkel
Journal:  J Neuromuscul Dis       Date:  2019

9.  Diagnostic approach to the congenital muscular dystrophies.

Authors:  Carsten G Bönnemann; Ching H Wang; Susana Quijano-Roy; Nicolas Deconinck; Enrico Bertini; Ana Ferreiro; Francesco Muntoni; Caroline Sewry; Christophe Béroud; Katherine D Mathews; Steven A Moore; Jonathan Bellini; Anne Rutkowski; Kathryn N North
Journal:  Neuromuscul Disord       Date:  2014-01-09       Impact factor: 4.296

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.